Join
Login
Submit Story

 .
View All


1
digs
Pharmaceutical Society of Australia Welcomes Preventive Health Agency Formation
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
The Federal Government's decision to introduce legislation to establish a preventive health agency has been welcomed by the Pharmaceutical Society of Australia which says pharmacists should play a key role in implementing the polices and strategies of the new agency.
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
MabThera Approved In Europe For Use In Patients With Previously-treated Chronic Lymphocytic Leukaemia
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has approved MabThera (rituximab) for use in patients with relapsed or refractory chronic lymphocytic leukaemia (CLL), the most common form of the disease in adults. The approval is supported by the impressive results from REACH, the largest randomised clinical trial ever reported in previously-treated CLL.
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
Sanofi Pasteur And Butantan Institute To Provide A(H1N1) Vaccine To Brazilian Government
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced it has signed an agreement with Butantan Institute for the production and supply of a vaccine against the novel A(H1N1) influenza virus for the Brazilian Government. This contract was announced during a state visit to Brazil by French President Nicolas Sarkozy.
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
Novartis Hosts Scientific Symposium In Philippines To Review Research Approaches, Clinical Management, And Growing Presence Of Dengue
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
The Novartis Institute for Tropical Diseases (NITD) is hosting a global symposium in the Philippines, bringing world-renowned Dengue experts together to discuss critical issues facing Dengue treatment and prevention. The four-day symposium will focus on best research practices and clinical management, as well as the growing global presence and unmet medical need to treat this neglected disease.
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
Novartis MF59® Adjuvanted Cell Culture-based Vaccine Shows Strong Immune Response In A(H1N1) Clinical Trials
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
A pilot trial of Novartis adjuvanted cell culture-based A(H1N1) vaccine[1] indicates that the "swine flu" vaccine elicited a strong immune response and was well tolerated. The trial was run by the UK's University of Leicester and University Hospitals of Leicester. The vaccine, to be called Celtura®, was tested with 100 healthy volunteers, aged between 18 and 50.
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
Groundbreaking Results In The RE-LY® Trial - Novel Oral Direct Thrombin Inhibitor Dabigatran Etexilate Convincingly Beats Warfarin
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
Boehringer Ingelheim announced data from the landmark RE-LY® study the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine.
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
Biogen Idec (NASDAQ: BIIB) today announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subjects AVONEX MS Prevention Study).
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
REGURIN(R) XL (trospium Chloride) Once Daily Tablets Now Available In The UK For The Treatment Of Overactive Bladder
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
Advancement Made In Automatic Autism Screen Increases Accuracy To 91%, Scheduled For Release This Month
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
LENA Foundation has increased the accuracy of the LENA Autism Screen (LAS) to 91 percent for children 24 to 48 months. LAS - the first automatic and totally objective autism screen is now as accurate or more accurate than other autism screens currently available to parents and clinicians.
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
Function Of A Neglected Structure In Neurons Revealed After 50 Years
submitted by DrKennedy 182 days ago (via medicalnewstoday.com)
Fifty years after it was originally discovered, scientists at the Friedrich Miescher Institute for Biomedical Research have elucidated the function of a microscopic network of tubules found in neurons. This structure modulates the strength of connections between two neurons, thereby contributing to our ability to learn and to adapt to new situations.
 
0 Comments - More Info - Bury   Topic: Health News





© 2009 www.RxSector.net - Content is available as Creative Commons Attribution-Share Alike 3.0 - Powered By PHPDug